{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:33:42Z","timestamp":1787582022304,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006738","name":"Medicinska Fakulteten, Lunds Universitet","doi-asserted-by":"publisher","award":["0"],"award-info":[{"award-number":["0"]}],"id":[{"id":"10.13039\/501100006738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk?nes universitetssjukhus","doi-asserted-by":"publisher","award":["."],"award-info":[{"award-number":["."]}],"id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12020-019-01852-w","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:21:07Z","timestamp":1550553667000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves\u2019 disease"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-1767","authenticated-orcid":false,"given":"Berglind","family":"Jonsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"1852_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4239\/wjd.v6.i1.67","volume":"6","author":"MP Hansen","year":"2015","unstructured":"M.P. Hansen, N. Matheis, G.J. Kahaly, Type 1 diabetes and polyglandular autoimmune syndrome: a review. World J. Diabetes 6, 67\u201379 (2015)","journal-title":"World J. Diabetes"},{"key":"1852_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","volume":"48","author":"AG Ziegler","year":"1999","unstructured":"A.G. Ziegler, M. Hummel, M. Schenker, E. Bonifacio, Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48, 460\u2013468 (1999)","journal-title":"Diabetes"},{"key":"1852_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"J.P. Krischer, K.F. Lynch, D.A. Schatz et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58, 980\u2013987 (2015)","journal-title":"Diabetologia"},{"key":"1852_CR4","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"A.G. Ziegler, M. Rewers, O. Simell et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473\u20132479 (2013)","journal-title":"JAMA"},{"issue":"7","key":"1852_CR5","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1007\/s00125-018-4605-3","volume":"61","author":"P Achenbach","year":"2018","unstructured":"P. Achenbach, M. I. Hawa, S. Krause, et al. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: action LADA 12. Diabetologia 61(7), 1644\u20131649 (2018).","journal-title":"Diabetologia"},{"key":"1852_CR6","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1210\/jc.2012-4309","volume":"98","author":"G Barbesino","year":"2013","unstructured":"G. Barbesino, Y. Tomer, Clinical review: clinical utility of TSH receptor antibodies. J. Clin. Endocrinol. Metab. 98, 2247\u20132255 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1852_CR7","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1056\/NEJMra030158","volume":"350","author":"GS Eisenbarth","year":"2004","unstructured":"G.S. Eisenbarth, P.A. Gottlieb, Autoimmune polyendocrine syndromes. N. Engl. J. Med. 350, 2068\u20132079 (2004)","journal-title":"N. Engl. J. Med."},{"key":"1852_CR8","first-page":"376","volume":"67","author":"A Driessche Van den","year":"2009","unstructured":"A. Van den Driessche, V. Eenkhoorn, L. Van Gaal, C. De Block, Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth. J. Med. 67, 376\u2013387 (2009)","journal-title":"Neth. J. Med."},{"key":"1852_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2796.1996.417758000.x","volume":"239","author":"B Hallengren","year":"1996","unstructured":"B. Hallengren, A. Falorni, M. Landin-Olsson, A. Lernmark, K.I. Papadopoulos, G. Sundkvist, Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J. Intern. Med. Suppl. 239, 63\u201368 (1996)","journal-title":"J. Intern. Med. Suppl."},{"key":"1852_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1530\/eje.0.1370503","volume":"137","author":"D Maugendre","year":"1997","unstructured":"D. Maugendre, F. Verite, I. Guilhem, B. Genetet, H. Allannic, M. Delamaire, Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients. Eur. J. Endocrinol. 137, 503\u2013510 (1997)","journal-title":"Eur. J. Endocrinol."},{"key":"1852_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.metabol.2010.07.025","volume":"60","author":"M Moriguchi","year":"2011","unstructured":"M. Moriguchi, S. Noso, Y. Kawabata et al. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Metabolism 60, 761\u2013766 (2011)","journal-title":"Metabolism"},{"key":"1852_CR12","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1210\/jc.2009-0747","volume":"94","author":"F Traisk","year":"2009","unstructured":"F. Traisk, L. Tallstedt, M. Abraham-Nordling et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J. Clin. Endocrinol. Metab. 94, 3700\u20133707 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1852_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0033-1363193","volume":"122","author":"M Lantz","year":"2014","unstructured":"M. Lantz, T. Planck, P. Asman, B. Hallengren, Increased TRAb and\/or Low Anti-TPO Titers at Diagnosis of Graves' Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset. Exp. Clin. Endocr. Diab 122, 113\u2013117 (2014)","journal-title":"Exp. Clin. Endocr. Diab"},{"key":"1852_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00408469","volume":"37","author":"CE Grubin","year":"1994","unstructured":"C.E. Grubin, T. Daniels, B. Toivola et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37, 344\u2013350 (1994)","journal-title":"Diabetologia"},{"key":"1852_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/JCI118188","volume":"96","author":"MA Payton","year":"1995","unstructured":"M.A. Payton, C.J. Hawkes, M.R. Christie, Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96, 1506\u20131511 (1995)","journal-title":"J. Clin. Invest."},{"key":"1852_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jim.2011.06.011","volume":"371","author":"F Vaziri-Sani","year":"2011","unstructured":"F. Vaziri-Sani, A.J. Delli, H. Elding-Larsson et al. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J. Immunol. Methods 371, 25\u201337 (2011)","journal-title":"J. Immunol. Methods"},{"key":"1852_CR17","unstructured":"Nationelle Diabetesregistret. \u00c5rsrrt. \n                    https:\/\/ndr.nu\/pdf\/Arsraport_NDR_2015_pdf\n                    \n                   (2015)."},{"key":"1852_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"E. Ahlqvist, P. Storm, A. Karajamaki et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinology 6, 361\u2013369 (2018)","journal-title":"Lancet Diabetes Endocrinology"},{"key":"1852_CR19","first-page":"306487","volume":"2011","author":"M Taniyama","year":"2010","unstructured":"M. Taniyama, A. Kasuga, C. Nagayama, K. Ito, Occurrence of type 1 diabetes in graves' disease patients who are positive for antiglutamic Acid decarboxylase antibodies: an 8-year followup study. J. Thyroid Res. 2011, 306487 (2010)","journal-title":"J. Thyroid Res."},{"key":"1852_CR20","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"R.A. Insel, J.L. Dunne, M.A. Atkinson et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964\u20131974 (2015)","journal-title":"Diabetes Care"},{"key":"1852_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1590\/2359-3997000000280","volume":"61","author":"C Sallorenzo","year":"2017","unstructured":"C. Sallorenzo, R. Silva, T. Kasamatsu, S. Dib, Prevalence of pancreatic autoantibodies in non-diabetic patients with autoimmune thyroid disease and its relation to insulin secretion and glucose tolerance. Arch. Endocrinol. Metab. 61, 361\u2013366 (2017)","journal-title":"Arch. Endocrinol. Metab."},{"key":"1852_CR22","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"J.M. Wenzlau, K. Juhl, L. Yu et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl Acad. Sci. USA 104, 17040\u201317045 (2007)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1852_CR23","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00125-013-2934-9","volume":"56","author":"B Jonsdottir","year":"2013","unstructured":"B. Jonsdottir, C. Andersson, A. Carlsson et al. Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents. Diabetologia 56, 1735\u20131742 (2013)","journal-title":"Diabetologia"},{"key":"1852_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/EJE-13-0901","volume":"170","author":"A Rogowicz-Frontczak","year":"2014","unstructured":"A. Rogowicz-Frontczak, D. Zozulilska-Ziolkiewicz, M. Litwinowicz, P. Niedzwiecki, K. Wyka, B. Wierusz-Wysocka, Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? Eur. J. Endocrinol. 170, 651\u2013658 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1852_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.numecd.2008.09.004","volume":"19","author":"C Murgia","year":"2009","unstructured":"C. Murgia, C. Devirgiliis, E. Mancini, G. Donadel, P. Zalewski, G. Perozzi, Diabetes-linked zinc transporter ZnT8 is a homodimeric protein expressed by distinct rodent endocrine cell types in the pancreas and other glands. Nutr. Metab. Cardiovasc. Dis. 19, 431\u2013439 (2009)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"1852_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-013-0032-x","volume":"45","author":"YV Li","year":"2014","unstructured":"Y.V. Li, Zinc and insulin in pancreatic beta-cells. Endocrine 45, 178\u2013189 (2014)","journal-title":"Endocrine"},{"key":"1852_CR27","first-page":"160","volume":"16","author":"RC Silva","year":"2003","unstructured":"R.C. Silva, C. Sallorenzo, C.E. Kater, S.A. Dib, A. Falorni, Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases. Diabetes Nutr. Metab. 16, 160\u2013168 (2003)","journal-title":"Diabetes Nutr. Metab."},{"key":"1852_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/347151a0","volume":"347","author":"S Baekkeskov","year":"1990","unstructured":"S. Baekkeskov, H.J. Aanstoot, S. Christgau et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151\u2013156 (1990)","journal-title":"Nature"},{"key":"1852_CR29","first-page":"1277","volume":"102","author":"B Jonsdottir","year":"2017","unstructured":"B. Jonsdottir, C. Larsson, A. Carlsson et al. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. J. Clin. Endocrinol. Metab. 102, 1277\u20131285 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1852_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2249.2001.01668.x","volume":"126","author":"CE Block De","year":"2001","unstructured":"C.E. De Block, I.H. De Leeuw, J.J. Vertommen et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin. Exp. Immunol. 126, 236\u2013241 (2001)","journal-title":"Clin. Exp. Immunol."},{"key":"1852_CR31","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.2337\/diabetes.51.5.1346","volume":"51","author":"J Graham","year":"2002","unstructured":"J. Graham, W.A. Hagopian, I. Kockum et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 51, 1346\u20131355 (2002)","journal-title":"Diabetes"},{"key":"1852_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1210\/jcem-51-4-863","volume":"51","author":"H Allannic","year":"1980","unstructured":"H. Allannic, R. Fauchet, Y. Lorcy et al. HLA and Graves' disease: an association with HLA-DRw3. J. Clin. Endocrinol. Metab. 51, 863\u2013867 (1980)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1852_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/eci.12404","volume":"45","author":"K Haller-Kikkatalo","year":"2015","unstructured":"K. Haller-Kikkatalo, K. Pruul, K. Kisand, V. Nemvalts, K. Reimand, R. Uibo, GADA and anti-ZnT8 complicate the outcome of phenotypic type 2 diabetes of adults. Eur. J. Clin. Invest. 45, 255\u2013262 (2015)","journal-title":"Eur. J. Clin. Invest."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01852-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01852-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:23:31Z","timestamp":1582053811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01852-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1852"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01852-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}